Candesartan antihypertensive survival evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients
Phase of Trial: Phase III
Latest Information Update: 17 Jan 2017
At a glance
- Drugs Candesartan cilexetil (Primary) ; Amlodipine
- Indications Cardiovascular disorders; Hypertension
- Focus Therapeutic Use
- Acronyms CASE-J; CASE-J Ex
- 06 Sep 2013 Additional lead trial centres added as reported by University Hospital Medical Information Network - Japan record.
- 01 Dec 2011 Extension study results published in Hypertension Research.
- 29 Aug 2010 Effects of pre-existing type 2 diabetes and CHD on outcomes presented at the Annual Congress of the European Society of Cardiology (ESC) 2010 meeting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History